Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Feb 21, 2024 5:51pm
87 Views
Post# 35891996

RE:RE:RE:RE:RE:RE:RE:ATM

RE:RE:RE:RE:RE:RE:RE:ATMI think you have answered your own question CM. Perhaps because they just don't have positive news on the horizon...

I would like to be positively surprised by management at least once in 20 years as a shareholder, and it's not long till the 4Q conf call... but if the past is anything to go by, I don't think we'll get anything new, besides the usual, "we had some interesting results", "patients are living longer..", "safe and well tolerated...", "we're in talks with partners..." yawn.

Whilst those who frequent this BB may have very different opinions on ONCY's prospects, I think without a doubt, most are frustrated that news of a partner has not been forthcoming...

They cannot run ANY phase III alone, and have stated this themselves for many years... so time for Matt and Co. to give some clarity to this pressing point. Only a week or so to wait.
<< Previous
Bullboard Posts
Next >>